AKT2 and central nervous system cancer: Importantly, we indicated that upregulation of ALKBH5 abrogated the ability of miR-193a-3p mimics to enhance glioma cell apoptosis through overexpression of AKT2 without affecting AKT1 and AKT3 expressions or activities.